Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Cancer and Ovarian Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06997029
What this trial is testing

BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorAdvanced Breast CancerAdvanced Ovarian Cancer
Bristol-Myers Squibb 234
Not applicableLooking for participantsNCT01789229
What this trial is testing

Establishment of a Tumor Bank for Tissue Samples

Who this might be right for
Ovarian NeoplasmsBreast NeoplasmsColorectal Neoplasms+3 more
Medical University of Vienna 10,000
Testing effectiveness (Phase 2)Study completedNCT03180294
What this trial is testing

Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer

Who this might be right for
Breast CarcinomaCervical CarcinomaOvarian Carcinoma+4 more
NRG Oncology 230
Not applicableUnknownNCT04235556
What this trial is testing

Integrated Care Pathway in Oncology (PASSION)

Who this might be right for
Colon CancerGastric CancerPancreatic Cancer+5 more
Assistance Publique - Hôpitaux de Paris 1,800
Not applicableStudy completedNCT03707574
What this trial is testing

Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study

Who this might be right for
Advanced Malignant NeoplasmAdvanced MelanomaAdvanced Renal Cell Carcinoma+51 more
National Cancer Institute (NCI) 64
Not applicableStudy completedNCT02351479
What this trial is testing

Hula, a Physical Activity Intervention for Female-Cancer Survivors

Who this might be right for
Physical ActivityBreast CancerCervical Cancer+2 more
University of Hawaii 73
Testing effectiveness (Phase 2)Ended earlyNCT01708161
What this trial is testing

A Phase Ib/II Study of the Combination of BYL719 Plus AMG 479 in Adult Patients With Selected Solid Tumors

Who this might be right for
PIK3CA Mutated Advanced Solid TumorsPIK3CA Amplified Advanced Solid Tumors
Novartis Pharmaceuticals 47
Not applicableUnknownNCT04197856
What this trial is testing

Direct Information to At-risk Relatives

Who this might be right for
Familial Breast CancerFamilial Colorectal CancerHereditary Breast and Ovarian Cancer Syndrome+2 more
Umeå University 490
Testing effectiveness (Phase 2)Study completedNCT01065441
What this trial is testing

Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer

Who this might be right for
Solid Tumors Stage II, Stage III and Stage IVBreast CancerColorectal Cancer+5 more
Michael Har-Noy 9
Not applicableStudy completedNCT04817501
What this trial is testing

Phenotypic Spectrum of CTCs in Tumors of the Female Reproductive System

Who this might be right for
Breast CancerOvarian CancerEndometrial Cancer
Tomsk National Research Medical Center of the Russian Academy of Sciences 150
Early research (Phase 1)Ended earlyNCT03621982
What this trial is testing

Study of ADCT-301 in Patients With Selected Advanced Solid Tumors

Who this might be right for
Head and Neck Cancer Squamous Cell CarcinomaNon-small Cell Lung CancerGastric Cancer+9 more
ADC Therapeutics S.A. 78
Not applicableActive Not RecruitingNCT01953159
What this trial is testing

Assessment of Paclitaxel-Induced Neuropathy

Who this might be right for
CancerBreast CancerOvarian Cancer
University of Chicago 43
Not applicableUnknownNCT02753036
What this trial is testing

Chemotherapy-induced Cognitive Alterations in Recruits With Ovarian and Breast Cancer

Who this might be right for
Cognition DisordersPolyneuropathies
Charite University, Berlin, Germany 72
Not applicableStudy completedNCT01139957
What this trial is testing

Incidence of Cancer in Women at Increased Genetic Risk of Ovarian Cancer

Who this might be right for
Breast CarcinomaFallopian Tube CarcinomaOvarian Neoplasm+1 more
Gynecologic Oncology Group 1,916
Early research (Phase 1)UnknownNCT05273944
What this trial is testing

Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection (Lipodox®) in Chinese Patients

Who this might be right for
Breast CancerOvarian Cancer
Shenzhen Kangzhe Pharmaceutical Co., Ltd. 80
Early research (Phase 1)Study completedNCT01975831
What this trial is testing

Evaluate MEDI4736 in Combination With Tremelimumab

Who this might be right for
Breast CancerOvarian CancerColorectal Cancer+2 more
Ludwig Institute for Cancer Research 104
Early research (Phase 1)Study completedNCT03000257
What this trial is testing

Budigalimab (ABBV-181) in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
AbbVie 182
Early research (Phase 1)Study completedNCT02743637
What this trial is testing

A Dose Escalation Study of SDX-7320 in Patients With Advanced Refractory or Late-Stage Solid Tumors

Who this might be right for
Advanced MalignancyAdvanced Solid TumorsNeoplasm+1 more
SynDevRx, Inc. 32
Very early researchStudy completedNCT02646319
What this trial is testing

Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations

Who this might be right for
Advanced Malignant NeoplasmCervical Squamous Cell CarcinomaEndometrial Carcinoma+29 more
Mayo Clinic 2
Not applicableStudy completedNCT03571841
What this trial is testing

Sexual Health and Rehabilitation After Ovarian Suppression Treatment

Who this might be right for
Breast Cancer SurvivorsSexual Function DisturbancesOvarian Suppression Treatment
Dana-Farber Cancer Institute 20
Next Page